GENEMATRIX INC. Q3 revenue KRW 2.5 billion, operating loss KRW 0.1 billion
AI summary · Not investment advice
Genematrix sold KRW 2.5 billion worth in Q3 and lost KRW 0.1 billion from its main business, turning to a loss from the previous quarter.
Operating profit · 3 months
KRW -132.5 million
Key facts
- Revenue (3 months)
- KRW 2.5 billion
- Net income (3 months)
- KRW -611.9 million
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 2.6 billion
- Revenue (year to date)
- KRW 7.9 billion
- Operating profit (prior-year 3 months)
- KRW -109.2 million
- Operating profit (year to date)
- KRW -66.3 million
- Net income (prior-year 3 months)
- KRW 265.8 million
- Net income (year to date)
- KRW -144.3 million
Commentary
AI commentary · Not investment advice
What happened
Genematrix reported its 3rd-quarter 2026 results on a standalone basis. Sales for the latest 3 months were KRW 2.48 billion. Sales for the same 3 months a year earlier were KRW 2.59 billion. Cumulative sales this year are KRW 7.91 billion.
In the company's terms
Operating profit (profit from the core business) for the latest 3 months was a loss of KRW 132.5 million. The company made an operating profit in the previous quarter, so this is a swing to a loss. A year earlier, the same 3 months showed a loss of KRW 109.2 million. The cumulative operating loss this year is KRW 66.3 million.
What changes for shareholders
Net income (the final profit after taxes and all other items) for the latest 3 months was a loss of KRW 611.9 million. A year earlier, the same 3 months showed a profit of KRW 265.8 million. The cumulative net loss this year is KRW 144.3 million.
Sales fell 4.1% from the same 3 months a year earlier. They fell 14.7% from the previous quarter.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
G